THE USE OF NUTRIENT RESTRICTION IN COMBINATION WITH CHEMOTHERAPY IN LEWIS’ LUNG CARCINOMA

The aim of the study was to evaluate the effect of nutrient restriction in combination with chemotherapy with methotrexate on the development of Lewis lung carcinoma (LLC) in mice.

Material and methods. LLC cells were inoculated into the thigh of adult C57BL/6j mice. Mice fasted twice, for 2 days each, with a day interval. Methotrexate (MTX) was used alone and in combination with nutrient restriction. The drug was administered intraperitoneally at the maximally tolerated dose. Treatment efficacy was evaluated by the tumor growth inhibition (TGI), the level of inhibition of lung metastases (IM) and the kinetic tumor growth index (GI).

Results. TGI was 34 %, 27 % and 46 % in mice with nutrient restriction alone, MTX alone and with combination of nutrient restriction and MTX, respectively. IM index was 90% and 70% in mice treated with MTX alone and in combination with nutrient restriction, respectively. There was no difference in IM index between mice subjected to restricted feeding and mice in the control group. GI was 0.7 in mice with nutrient restriction and combination of nutrient restriction and MTX. GI was 0.81 in mice treated with MTX monotherapy. The toxic effect of MTX was manifested by weight loss in mice. Weigh loss by 13% and 17% was observed in mice subjected to nutrient restriction alone and in combination with MTX, respectively.

Conclusion. MTX inhibited cancer cell growth, however, the therapeutic effect of MTX was leveled by toxic effect on mice. Prolonged caloric restriction inhibited primary tumor growth. However, after returning to a normal diet, tumor growth resumed quickly. The use of MTX in combination with caloric restriction increased its anti-tumor effect on the primary tumor, decreased its toxic effect, but reduced its anti-metastatic activity by 20 %.

1. Chabner B.A., Roberts Jr.T.G. Timeline: chemotherapy and the war on cancer. Nat Rev Cancer. 2005 Jan; 5 (1): 65–72. doi:10.1038/nrc1529.

2. Gervas P.A., Litviakov N.V., Popova N.O., Dobrodeev A.Yu., Tarasova A.S., Yumov E.L., Ivanova F.G., Cheremisina O.V., Afanasyev S.G., Goldberg V.E., Cherdyntseva N.V. Problem and perspective to improve molecular testing to choose appropriate target therapy. Siberian Journal of Oncology. 2014; 2: 46–55. [in Russian]

3. Links M., Lewis C. Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy. Drugs. 1999 Mar; 57 (3): 293–308.

4. De Lorenzo M.S., Baljinnyam E., Vatner D.E., Abarzua P., Vatner S.F., Rabson A.B. Caloric restriction reduces growth of mammary tumors and metastases. Carcinogenesis. 2011 Sep; 32 (9): 1381–7. doi: 10.1093/carcin/bgr107.

5. Mulrooney T.J., Marsh J., Urits I., Seyfried T.N., Mukherjee P. Influence of caloric restriction on constitutive expression of NF-kappaB in an experimental mouse astrocytoma. PLoS One. 2011 Mar 30; 6(3): e18085. doi: 10.1371/journal.pone.0018085.

6. Sheldon W.G., Bucci T.J., Hart R.W., Turturro A. Age-related neoplasia in a lifetime study of ad libitum-fed and food-restricted B6C3F1 mice. Toxicol Pathol. 1995 Jul-Aug; 23 (4): 458–76. doi: 10.1177/019262339502300403.

7. Weindruch R., Walford R.L. Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science. 1982 Mar 12; 215 (4538): 1415–8.

8. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., Allison D.B., Cruzen C., Simmons H.A., Kemnitz J.W., Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009 Jul 10; 325 (5937): 201–204. doi: 10.1126/science.1173635.

9. Fontana L., Weiss E.P., Villareal D.T., Klein S., Holloszy J.O. Longterm effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 2008 Oct; 7(5): 681–7.

10. Renehan A.G., Zwahlen M., Minder C., O’Dwyer S.T., Shalet S.M., Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004 Apr 24; 363 (9418): 1346–53. doi:10.1016/S0140-6736(04)16044-3.

11. Walford R.L., Mock D., Verdery R., MacCallum T. Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol A Biol Sci Med Sci. 2002 Jun; 57 (6): B211–24. doi: 10.1093/gerona/57.6.B211.

12. Senichkin V.V., Kopeina G.S., Zamaraev A.V,. Lavrik I.N., Zhivotovskij B.D. Restriction of nutrients as an approach to combined therapy of tumors. Mol Medicine. 2016; 50 (3): 416–434. [in Russian]

13. Doyle C., Kushi L.H., Byers T., Courneya K.S., Demark-Wahnefried W., Grant B., McTiernan A., Rock C.L., Thompson C., Gansler T., Andrews K.S.; 2006 Nutrition, Physical Activity and Cancer Survivorship Advisory Committee; American Cancer Society. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2006 Nov-Dec; 56 (6): 323–53.

14. Lee C., Raffaghello L., Brandhorst S., Safdie F.M., Bianchi G., Martin-Montalvo A., Pistoia V., Wei M., Hwang S., Merlino A., Emionite L., de Cabo R., Longo V.D. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012 Mar 7; 4 (124): 124ra27. doi: 10.1126/scitranslmed.3003293.

15. Raffaghello L., Lee C., Safdie F.M., Wei M., Madia F., Bianchi G., Longo V.D. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci USA. 2008 Jun 17; 105 (24): 8215–20. doi: 10.1073/pnas.0708100105.

16. Safdie F., Brandhorst S., Wei M., Wang W., Lee C., Hwang S., Conti P.S., Chen T.C., Longo V.D. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One. 2012; 7 (9): e44603. doi: 10.1371/journal.pone.0044603.

17. Bishop N.A., Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet. 2007 Nov; 8 (11): 835–44. doi:10.1038/nrg2188.

18. Fontana L., Partridge L., Longo V.D. Extending healthy life span--from yeast to humans. Science. 2010 Apr 16; 328 (5976): 321–6. doi: 10.1126/science.1172539.

19. Laviano A., Rossi F.F. Toxicity in chemotherapy – when less is more. N Engl J Med 2012; 366: 2319–2320. doi: 10.1056/NEJMcibr1202395.

20. Longo V.D., Mattson M.P. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014 Feb 4; 19 (2): 181–92. doi: 10.1016/j.cmet.2013.12.008.

21. Korshunov D.A., Korshunova Z.V., Kondakova I.V. Inhibitors of carbohydrate metabolism in the therapy of malignant neoplasms. Mol Medicine. 2016; 14 (1): 3–7. [in Russian]

22. Korshunov D.A., Petrova Z.V., Kondakova I.V. Antitumor targets in glycolytic metabolism of malignant neoplasms. Journal of N.N. Blokhin Russian Cancer Research Center RAMS. 2014; 25 (3–4): 35–42. [in Russian]

23. Emanuel‘ N.M. Kinetics of experimental tumor processes. Moscow, 1977. 416. [in Russian]

24. Treshchalina E.M., Zhukova O.S., Gerasimova G.K., Andronova N.V., Garin A.M. Methodical instructions for the study of the antitumor activity of pharmacological substances. A guide to preclinical drug research. Part one. Moscow, 2012. 640–654. [in Russian]

25. Strukov A.N., Ivanova M.A., Nikitin A.K., Sorokin G.M., Kon’kov S.A. Tumor growth index as an integral criterion of the effectiveness of antitumor therapy in the experiment. Problems of Oncology. 2001; 47 (5): 616–618. [in Russian]

26. Ganti V., Walker E.A., Nagar S. Pharmacokinetic application of a bio-analytical LC-MS method developed for 5-fluorouracil and methotrexate in mouse plasma, brain and urine. Biomed Chromatogr. 2013 Aug; 27 (8): 994–1002. doi: 10.1002/bmc.2893.

27. Lobo E.D., Balthasar J.P. Pharmacokinetic-pharmacodynamic modeling of methotrexate-induced toxicity in mice. J Pharm Sci. 2003 Aug; 92 (8): 1654–64. doi:10.1002/jps.10431.

28. Potten C.S. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci. 1998 Jun 29; 353 (1370): 821–30. doi: 10.1098/rstb.1998.0246.